Clinical Research Directory
Browse clinical research sites, groups, and studies.
Long-term Cognitive, Neuropsychiatric and Functional Outcomes in Adults Who Have Received Chimeric Antigen-Receptor T-Cell (CAR-T) Therapy for Aggressive Lymphoma at Stanford
Sponsor: Stanford University
Summary
This study aims to assess the feasibility of performing neuropsychological testing to measure the cognitive performance of individuals following Axicabtagene ciloleucel CAR-T therapy at Stanford.
Official title: Long-term Cognitive, Neuropsychiatric and Functional Outcomes in Adults Who Have Received Chimeric Antigen-Receptor T-Cell (CAR-T) Therapy for Aggressive Lymphoma at Stanford - A Pilot Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2025-12
Completion Date
2027-12
Last Updated
2025-02-11
Healthy Volunteers
No
Conditions
Interventions
Neuropsychological testing
Upon completion of the consent, the subject will be booked into an available 90 minute in-person or remote neuropsychological testing
Locations (1)
Stanford Cancer Center
San Francisco, California, United States